All News

Venkata R. Jayanthi, MD, has been appointed chief of the section of pediatric urology at Nationwide Children's Hospital, Columbus, OH.

When parents say their child's urine smells bad, physicians should test for a urinary tract infection, Canadian researchers report.

Patients taking oral fluoroquinolones had a higher risk of developing a retinal detachment compared with nonusers, although the absolute risk was small, according to a recent study.

The FDA's Reproductive Health Drugs Advisory Committee recently voted that the overall risk/benefit assessment supports approval of the investigational agent mirabegron for the treatment of overactive bladder.

An international research team led by investigators from Weill Cornell Medical College, New York has discovered two inherited-genetic deletions in the human genome linked to the development of aggressive prostate cancer.

The AUA Foundation announced that Astellas U.S. has awarded a $1.2 million independent educational grant to continue its support of young academic urologists through the AUA Foundation/Astellas Rising Stars in Urology Award program.

Prostatic artery embolization may be an effective treatment for men suffering from symptoms of an enlarged prostate, researchers said at the Society of Interventional Radiology annual scientific meeting in San Francisco.

Kidney stones in fruit flies may hold the key to developing a treatment that could stop the formation of stones in humans, according to a research team from Mayo Clinic and the University of Glasgow.

A class I histone deacetylase inhibitor, entinostat, has been shown to boost the effectiveness of cancer immunotherapy for treatment of some solid tumors, including kidney and prostate cancer, according to preclinical research by a team from Roswell Park Cancer Institute.

Effective advocacy depends on data, relationships, and, for lack of a better term, money.

Three urologists share their favorite instrument used in their practices.

Early results from a registry of patients with small renal masses support the safety of active surveillance using a standardized protocol.

Margaret S. Pearle, MD, PhD, discusses the scope of radiation exposure and how to minimize risk from it.

Two additional years of results from the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirm original findings that screening significantly reduces death from prostate cancer.

Jim C. Hu, MD, MPH, will join the UCLA urology faculty in April 2012.

Ohio state Senator Nina Turner (D-Cleveland) recently announced legislation that she says would protect men in Ohio from the risks of phosphodiesterase type-5 inhibitors used to treat erectile dysfunction.

Quest Diagnostics (Madison, NJ) recently announced the availability of a molecular blood test for identifying renal organ-transplant rejection.

Circumcision before a male's first sexual intercourse may help protect against prostate cancer, according to a recent study.

Khurshid Guru, MD, director of the Center for Robotic Surgery at Roswell Park Cancer Institute, Buffalo, NY, has been named the Dr. Robert P. Huben Professor of Urologic Oncology.

Spanish researchers have found that early-onset androgenetic alopecia (AGA) may be a marker of urinary symptoms associated with BPH.

Treatment is still overused in older men with prostate cancer and a short life expectancy, say the authors of a study from Yale School of Medicine, New Haven, CT.

High percentages of radiation oncologists and medical oncologists discuss the impact of cancer treatments on fertility with their patients of childbearing age, but the frequency of these discussions varies widely by specialty, according to a recent study.

Janssen Research & Development, LLC, recently has unblinded the phase III study of the androgen biosynthesis inhibitor abiraterone acetate (ZYTIGA) plus prednisone for the treatment of asymptomatic or mildly symptomatic patients with metastatic castration-resistant prostate cancer (CRPC) who have not received chemotherapy.

Urologic oncologist Steven E. Canfield, MD, has been named chief of the division of urology in the department of surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School.

The FDA recently approved the InTone device (InControl Medical, LLC, Brookfield, WI) to treat female urinary incontinence.

Male fetuses of mothers that are exposed to radiation during early pregnancy may have an increased chance of developing testicular cancer, report researchers from the University of Texas MD Anderson Cancer Center, Houston.

Men receiving testosterone supplementation who also receive the 5-alpha-reductase inhibitor dutasteride (Avodart) do not experience a significant difference in changes in muscle mass, muscle strength, or sexual function compared with men who do not receive dutasteride, according to a recent study.